Cargando…
Human Vaccines & Immunotherapeutics: News
Measles vaccination: Targeted and non-targeted benefits CDC reports: 2-dose regimen of chickenpox vaccine is a success Positive preliminary results from the CAPiTA study Seasonal flu vaccine associate with reduced stroke risk HPV vaccine shown to halve cervical abnormalities Global prize for mobile...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896530/ http://dx.doi.org/10.4161/hv.29050 |
_version_ | 1782436029688446976 |
---|---|
author | Riedmann, Eva M |
author_facet | Riedmann, Eva M |
author_sort | Riedmann, Eva M |
collection | PubMed |
description | Measles vaccination: Targeted and non-targeted benefits CDC reports: 2-dose regimen of chickenpox vaccine is a success Positive preliminary results from the CAPiTA study Seasonal flu vaccine associate with reduced stroke risk HPV vaccine shown to halve cervical abnormalities Global prize for mobile mast vaccine storage project Developmental pathway of potent HIV-neutralizing antibodies Burkholderia vaccine: US Dep of Defense collaborates with Bavarian Nordic |
format | Online Article Text |
id | pubmed-4896530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-48965302016-06-24 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M Hum Vaccin Immunother News, Policy & Profiles Measles vaccination: Targeted and non-targeted benefits CDC reports: 2-dose regimen of chickenpox vaccine is a success Positive preliminary results from the CAPiTA study Seasonal flu vaccine associate with reduced stroke risk HPV vaccine shown to halve cervical abnormalities Global prize for mobile mast vaccine storage project Developmental pathway of potent HIV-neutralizing antibodies Burkholderia vaccine: US Dep of Defense collaborates with Bavarian Nordic Taylor & Francis 2014-04-29 /pmc/articles/PMC4896530/ http://dx.doi.org/10.4161/hv.29050 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | News, Policy & Profiles Riedmann, Eva M Human Vaccines & Immunotherapeutics: News |
title | Human Vaccines & Immunotherapeutics: News |
title_full | Human Vaccines & Immunotherapeutics: News |
title_fullStr | Human Vaccines & Immunotherapeutics: News |
title_full_unstemmed | Human Vaccines & Immunotherapeutics: News |
title_short | Human Vaccines & Immunotherapeutics: News |
title_sort | human vaccines & immunotherapeutics: news |
topic | News, Policy & Profiles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896530/ http://dx.doi.org/10.4161/hv.29050 |
work_keys_str_mv | AT riedmannevam humanvaccinesimmunotherapeuticsnews |